Imagin Medical is a surgical imaging company focused on establishing a new standard of care in visualizing cancer during minimally invasive surgeries. The company's initial target is bladder cancer, a major cancer worldwide, the sixth most prevalent in the U.S., and most costly cancer to treat due to greater than 50% recurrence rate.
Imagin Medical is developing the i/Blue™ Imaging System to significantly improve surgeons’ ability to visualize cancerous cells and enable more accurate bladder cancer resection. Using innovative optic and light sensor technology, the i/Blue System combines the advantages of white and blue light cystoscopy with fluorescing contrast agents to simultaneously display white and blue light images on the surgical monitor, side-by-side, in real-time. Based on functional prototype demonstrations, leading urologists have indicated that this feature could make bladder cancer detection and removal more accurate and efficient, potentially reducing recurrence rates.
